RESUMO
The potential value of selective and non-selective COX-2 inhibitors in preventing some of the biochemical changes induced by ionizing radiation was studied in rats exposed to carrageenan-induced paw edema and 6-day-old air pouch models. The animals were exposed to different exposure levels of gamma-radiation, namely either to single doses of 2 and 7.5 Gy or a fractionated dose level of 7.5 Gy delivered as 0.5 Gy twice weekly for 7.5 weeks. The inflammatory response produced by carrageenan in irradiated rats was markedly higher than that induced in non-irradiated animals, and depended on the extent of irradiation. Celecoxib, a selective COX-2 inhibitor, in doses of 3, 5, 10, and 15 mg/kg was effective in reducing paw edema in irradiated and non-irradiated rats in a dose-dependent manner as well as diclofenac (3 mg/kg), a non-selective COX inhibitor. Irradiation of animals before the induction of the air pouch by an acute dose of 2 Gy led to a significant increase in leukocytic count, as well as in the level of interleukin-6 (IL-6), interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), LTB(4), PGE(2) (as an index of COX-2 activity), TXB(2) (as an index of COX-1 activity), and the plasma level of MDA. This increase in level of these parameters was more marked than that observed in the non-irradiated animals subjected to the inflammagen. The blood GSH level was not affected by the dose of irradiation used, whereas superoxide dismutase (SOD) activity was suppressed. In many respects, celecoxib (5 mg/kg) was as potent as diclofenac in decreasing the elevated levels of IL-6, IL-1beta, TNF-alpha, LTB(4), PGE(2), but lacked any significant effect on TXB(2) level. Since it is mostly selective for COX-2 with a rare effect on COX-1 enzyme, both drugs at the selected dose levels showed no effect on level of MDA, GSH, and SOD activity.
Assuntos
Inibidores de Ciclo-Oxigenase 2/farmacologia , Inflamação/prevenção & controle , Pirazóis/farmacologia , Lesões Experimentais por Radiação/prevenção & controle , Sulfonamidas/farmacologia , Doença Aguda , Animais , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/farmacologia , Celecoxib , Inibidores de Ciclo-Oxigenase 2/administração & dosagem , Inibidores de Ciclo-Oxigenase/farmacologia , Diclofenaco/farmacologia , Relação Dose-Resposta a Droga , Relação Dose-Resposta à Radiação , Raios gama/efeitos adversos , Inflamação/etiologia , Inflamação/fisiopatologia , Masculino , Pirazóis/administração & dosagem , Lesões Experimentais por Radiação/fisiopatologia , Ratos , Ratos Wistar , Sulfonamidas/administração & dosagemRESUMO
Fluphenazine caused a small decrease in the noradrenaline (NA) concentrations of the rat brain, possibly by impairing granular amine storage. The drug diminished the rise in brain and heart NA concentrations induced by pargyline, suggesting that it might posses inhibitory properties on neuronal uptake mechanisms and/or NA synthesis. Fluphenazine abolished conditioned avoidance responses in rats, an effect which was maintained after the concomitant administration of pargyline, when NA concentrations remained high. This suggests that the fluphenazine-induced sedation is not mediated via its effect on brain NA content, but is possibly due to the effect of the drug on NA turnover rates in the brain.
Assuntos
Flufenazina/farmacologia , Norepinefrina/análise , Pargilina/farmacologia , Animais , Aprendizagem da Esquiva/efeitos dos fármacos , Comportamento Animal/efeitos dos fármacos , Encéfalo/metabolismo , Química Encefálica/efeitos dos fármacos , Depressão Química , Coração/efeitos dos fármacos , Masculino , Miocárdio/análise , Miocárdio/metabolismo , Norepinefrina/metabolismo , Ratos , Reserpina/farmacologiaRESUMO
The effect of radiation exposure on the inflammatory process was studied in rats using the carrageenan-induced paw oedema and adjuvant-induced arthritis tests. Irradiation (0.5,1 and 2 Grays) resulted in a significant augmentation of the tissue response to carrageenan and the early phase of adjuvant-induced arthritis, but suppressed the late phase. Diclofenac (1-5 mg kg-1) effectively reduced the exaggerated inflammatory response in irradiated animals in both the carrageenan paw oedema and adjuvant-induced arthritis tests. The drug also had a prophylactic value in guarding against the induction of radiation damage. The inflammatory responses produced by irradiation and the benefits obtained by drug treatment may be related to changes in tissue prostaglandin levels and/or changes in the immune system.
Assuntos
Diclofenaco/farmacologia , Inflamação/fisiopatologia , Fenilacetatos/farmacologia , Lesões Experimentais por Radiação/fisiopatologia , Animais , Carragenina , Inflamação/etiologia , Masculino , Ratos , Fatores de TempoRESUMO
We examined the effect of parasitologic cure of S. mansoni infection on liver fibrosis in mice. Praziquantel, 250 mg/kg body weight, was administered orally to mice 8 weeks after infection with 50 S. mansoni cercariae. We assessed liver fibrosis by chemical measurement of collagen content as measured by the estimation of hydroxyproline and by histologic examination at the time of treatment, and at 10 and 20 weeks post-treatment, in comparison with the same measurements in untreated S. mansoni-infected mice and age-matched normal control mice. The extent of infection was monitored by liver egg counts. Compared to normal uninfected mice, mice with untreated S. mansoni infection showed steady accumulation of liver collagen at the 3 measurement periods, reaching an average level of 15-fold greater than that found in normal mice at 28 weeks after infection. Mice treated with praziquantel showed a prompt decrease in S. mansoni liver egg load with no viable eggs 10 weeks after treatment. Liver fibrosis was modestly diminished in treated mice compared to untreated controls 10 weeks after treatment; fibrosis was arrested and liver collagen content had diminished to normal levels by 20 weeks after treatment. No praziquantel toxicity was noted. The survival of treated mice was markedly greater than that of untreated infected animals. We conclude that parasitologic cure of murine S. mansoni infection is followed by arrest and eventual partial reversal of liver fibrosis under the conditions employed.
Assuntos
Isoquinolinas/uso terapêutico , Fígado/patologia , Praziquantel/uso terapêutico , Esquistossomose/tratamento farmacológico , Animais , Colágeno/análise , Granuloma/patologia , Hidroxiprolina/análise , Fígado/análise , Fígado/parasitologia , Hepatopatias/patologia , Masculino , Camundongos , Tamanho do Órgão , Contagem de Ovos de Parasitas , Schistosoma mansoni , Esquistossomose/parasitologia , Esquistossomose/patologiaRESUMO
The effects of praziquantel on cellular and humoral immune responses were studied in Swiss Albino mice and compared with the effects of potassium antimony tartrate. The experimental animals were antigenically primed by intravenous injection of Schistosoma mansoni eggs; the test drugs were given one day before egg injection and their effects monitored 16 days later. The size of the experimentally-induced pulmonary granulomata, immediate and delayed antigen-induced foot pad swelling, in vitro macrophage migration inhibition and the percentage of lymphocytes forming antibody and complement-dependent rosettes with erythrocytes (% EAC-R) were parameters used to assess the effect of the drugs. Praziquantel suppressed the size of pulmonary granulomata and the immediate and delayed foot pad reaction. Macrophage migration inhibition and the percentage of lymphocytes forming EAC-rosettes were not significantly affected. Tartar emetic was more effective as an immunosuppressant drug in these tests than praziquantel.
Assuntos
Granuloma/imunologia , Isoquinolinas/uso terapêutico , Pneumopatias/imunologia , Praziquantel/uso terapêutico , Esquistossomose/imunologia , Animais , Formação de Anticorpos/efeitos dos fármacos , Tartarato de Antimônio e Potássio/uso terapêutico , Inibição de Migração Celular , Granuloma/tratamento farmacológico , Hipersensibilidade Tardia/tratamento farmacológico , Hipersensibilidade Imediata/tratamento farmacológico , Pneumopatias/tratamento farmacológico , Linfócitos/imunologia , Macrófagos/imunologia , Camundongos , Formação de Roseta , Esquistossomose/tratamento farmacológicoRESUMO
The aqueous extract of propolis has been formulated as a nutritional food product and administered, as an adjuvant to therapy, to patients with mild to moderate asthma daily for 2 months in the framework of a comparative clinical study in parallel with a placebo preparation. The diagnosis of asthma was made according to the criteria of patient classification of the National Institutes of Health and Global Initiative for Asthma Management. At inclusion, the pulmonary forced expiratory volume in the first second (FEV1) as a percentage of the forced vital capacity (FVC) was more than 80% in mild persistent cases, and between 60 and 80% in moderate persistent cases, showing an increase in the degree of reversibility of > 15% in FEV1. All patients were on oral theophylline as controller therapy, none was receiving oral or inhaled corticosteroids, none had other comorbidities necessitating medical treatment, and all were from a middle-class community and had suffered from asthma for the last 2-5 years. Twenty-four patients received the placebo, with one drop-out during the study, while 22 received the propolis extract, with no drop-outs. The age range of the patients was 19-52 years; 36 were male and 10 female. The number of nocturnal attacks was recorded on a weekly basis, while pulmonary function tests were performed on all patients at the beginning of the trial, 1 month later and at the termination of the trial. Immunological parameters, including various cytokines and eicosanoids known to play a role in asthma, were measured in all patients at the beginning of the trial and 2 months later. Analysis of the results at the end of the clinical study revealed that patients receiving propolis showed a marked reduction in the incidence and severity of nocturnal attacks and improvement of ventilatory functions. The number of nocturnal attacks dropped from an average of 2.5 attacks per week to only 1. The improvement in pulmonary functions was manifested as a nearly 19% increase in FVC, a 29.5% increase in FEV1, a 30% increase in peak expiratory flow rate (PEFR), and a 41% increase in the forced expiratory flow rate between 25 and 75% of the vital capacity (FEF25-75). The clinical improvement was associated with decreases by 52, 65, 44 and 30%, respectively, of initial values for the pro-inflammatory cytokines tumor necrosis factor (TNF)-alpha, ICAM-1, interleukin (IL)-6 and IL-8, and a 3-fold increase in the 'protective' cytokine IL-10. The levels of prostaglandins E2 and F2alpha and leukotriene D4 were decreased significantly to 36, 39, and 28%, respectively, of initial values. Patients on the placebo preparation showed no significant improvement in ventilatory functions or in the levels of mediators. The findings suggest that the aqueous propolis extract tested is potentially effective as an adjuvant to therapy in asthmatic patients. The benefits may be related to the presence in the extract of caffeic acid derivatives and other active constituents.
Assuntos
Anti-Inflamatórios/administração & dosagem , Asma/tratamento farmacológico , Suplementos Nutricionais , Própole/administração & dosagem , Adulto , Animais , Feminino , Humanos , Molécula 1 de Adesão Intercelular/sangue , Interleucina-8/sangue , Leucotrienos/sangue , Masculino , Medicina Tradicional , Pessoa de Meia-Idade , Leite , Testes de Função RespiratóriaRESUMO
The rabbit stomach serosal strip, was found to contract to adrenaline and noradrenaline but not to isoprenaline. The contractile response could be totally abolished by phenoxybenzamine but was not influenced by propranolol, indicating that the preparation has almost exclusively alpha-adrenoceptors. The responses to adrenaline and noradrenaline were markedly potentiated in the presence of monoamine oxidase inhibitors, guanethidine or reserpine, indicating the presence of MAO activity in the tissue and possible catecholamine stores. The functional state of the latter has not been conclusively established, since tyramine, an indirectly acting amine, was unable to elicit a response qualitatively similar to that of adrenaline, even in the presence of nialamide or tranylcypromine.
Assuntos
Inibidores da Monoaminoxidase/farmacologia , Estômago/efeitos dos fármacos , Sistema Nervoso Simpático/efeitos dos fármacos , Simpatolíticos/farmacologia , Animais , Epinefrina/farmacologia , Guanetidina/farmacologia , Técnicas In Vitro , Nialamida/farmacologia , Norepinefrina/farmacologia , Coelhos , Reserpina , Membrana Serosa/efeitos dos fármacos , Fatores de Tempo , Tranilcipromina/farmacologiaRESUMO
The effect of acute and chronic treatments of the calcium-channel blockers, isradipine, diltiazem and flunarizine in protecting against lorazepam dependence has been demonstrated in mice. Dependence was induced by twice-daily administration of lorazepam (1 mg kg-1) for 10 days, doubling the dose during the next 10 days. Withdrawal symptoms and changes in the noradrenaline, dopamine and 5-hydroxytryptamine content of different regions of the brain were observed after either 24-h withdrawal or flumazenil administration. Isradipine inhibited lorazepam withdrawal symptoms, the effect being accompanied in the 24-h withdrawal group by significant decreases in the noradrenaline and dopamine content of the thalamus and hypothalamus and in the noradrenaline content of the mid-brain. In the flumazenil-treated group isradipine produced significant decreases in mid-brain noradrenaline and dopamine levels and in the dopamine content of the thalamus and hypothalamus. Diltiazem did not, on the other hand, afford significant protection against lorazepam withdrawal symptoms and did not induce any significant change in the neurotransmitters studied. Flunarizine significantly inhibited lorazepam withdrawal symptoms, an effect accompanied by significant reduction in noradrenaline and dopamine levels in the thalamus and hypothalamus. Dopamine was also significantly reduced in the cerebral cortex. Similar effects were produced in the flumazenil-treated group, and the noradrenaline content was reduced in the medulla, pons and cerebellum. It was concluded that isradipine and flunarizine might be of value in ameliorating lorazepam withdrawal symptoms.
Assuntos
Bloqueadores dos Canais de Cálcio/farmacologia , Lorazepam , Transtornos Relacionados ao Uso de Substâncias/prevenção & controle , Animais , Química Encefálica/efeitos dos fármacos , Bloqueadores dos Canais de Cálcio/administração & dosagem , Diltiazem/administração & dosagem , Diltiazem/farmacologia , Dopamina/análise , Flunarizina/administração & dosagem , Flunarizina/farmacologia , Isradipino/administração & dosagem , Isradipino/farmacologia , Lorazepam/efeitos adversos , Masculino , Camundongos , Norepinefrina/análise , Serotonina/análise , Síndrome de Abstinência a Substâncias/metabolismo , Síndrome de Abstinência a Substâncias/prevenção & controle , Transtornos Relacionados ao Uso de Substâncias/metabolismoRESUMO
Schistosoma haematobium cercarial host-finding responses differ from those of Schistosoma mansoni. The attachment response to warm substrata is more sensitive and intense and is inhibited by unphysiologically warm substrata. Attachment is also stimulated by L-arginine as the exclusive chemical cue of the human skin surface (threshold 3 microM); however, the response is drastically lower than that of S. mansoni cercariae. No chemical host stimulus could be identified for an enduring contact with the host after attachment. After attachment, the cercariae creep in a temperature gradient toward heat source; their response is, however, more sensitive than that of S. mansoni (threshold 0.03 vs. 0.15 C/mm). Creeping S. haematobium cercariae orientate in chemical gradients in the same way as S. mansoni cercariae toward L-arginine as the exclusive chemical signal of the human skin surface. The selective benefit of this behavior is not yet understood. The penetration of both species is stimulated by free fatty acids from the human skin surface, not by heat. Thus, S. haematobium responds more to thermal host signals, whereas S. mansoni prefers chemical host signals.
Assuntos
Schistosoma haematobium/fisiologia , Schistosoma mansoni/fisiologia , Pele/parasitologia , Animais , Arginina/metabolismo , Meios de Cultura , Ácidos Graxos/metabolismo , Interações Hospedeiro-Parasita , Temperatura Alta , Humanos , Movimento , Pele/química , NataçãoRESUMO
Whole body exposure to gamma radiation has been experimentally shown to exaggerate inflammatory responses and to enhance the release of mediators. A thirteen per cent aqueous extract of propolis (bee glue) was previously shown to have potent antiinflammatory activity. The present study was carried out to show whether the extract could influence the exaggerated inflammatory response in irradiated animals. Rats were exposed to acute (2 and 6 Gy) & fractionated (1 Gy/week) doses of gamma ionizing radiation. Treatment with the aqueous extract orally (5 ml/kg) before and after radiation exposure markedly reduced the exaggerated paw oedema response to carrageenan. In the acute phase of adjuvant-induced arthritis, exposure to ionizing radiation caused an increase in serum acid phosphatase level. Malondialdehyde concentration in plasma and superoxide dismutase activity in blood significantly increased. Treatment with aqueous propolis extract prior to irradiation reduced malondialdehyde concentration in plasma and normalized the serum acid phosphatase level. The extract stimulated the release of superoxide dismutase enzyme. Aqueous propolis extract could possibly be of therapeutic value in protecting against inflammatory responses induced by gamma radiation.
Assuntos
Própole/uso terapêutico , Lesões Experimentais por Radiação/prevenção & controle , Animais , Raios gama , Inflamação/prevenção & controle , Masculino , Distribuição Aleatória , RatosRESUMO
An experimental in vivo model for studying cartilage destruction has been used to study the possible chondroprotective effect of the unsaponifiable constituents of avocado, soya and their combination at a ratio of 1:2. The method consists of implanting rat articular cartilage wrapped in cotton subcutaneously in mice, treating the animals daily for 2 weeks with the preparations in question, then sacrificing the animals and measuring some biochemical parameters related to cartilage integrity. The chosen parameters involved the glycosaminoglycan and hydroxyproline content of the cartilage, as well as the hydroxyproline content of beta-D-glucosaminidase activity of the granulomatous tissue induced by the cotton covering the cartilage. The unsaponifiables of both avocado and soya significantly reduced the degenerative changes induced by the granuloma tissue on the implanted cartilage in control animals as reflected by the preservation of the glycosaminoglycan and hydroxyproline content, and also reduced the proliferation of hydroxyproline and beta-D-glucosaminidase activity of the granulomatous tissue. The effect was even more marked when animals were treated with the combination of the two unsaponifiables at a 1:2 ratio. The preservation of the cartilage from destruction may have been associated with a diminished release of inflammatory mediators due to the effects of the unsaponifiables. In this context, the results point to a possible "chondroprotective" effect of these agents in vivo. This is in keeping with previous reports of chondroprotection by these unsaponifiables in vitro. The effect of the fixed dose combination in the 1:2 ratio was dose dependent.
Assuntos
Anti-Inflamatórios/farmacologia , Cartilagem Articular/efeitos dos fármacos , Granuloma/tratamento farmacológico , Óleos de Plantas/farmacologia , Óleo de Soja/farmacologia , Animais , Cartilagem Articular/citologia , Cartilagem Articular/transplante , Granuloma/patologia , Camundongos , Ratos , Transplante HeterólogoRESUMO
Propolis is a natural product produced by the honey bee. The extract contains amino acids, flavanoids, terpenes and cinnamic acid derivatives. In various in vitro models propolis extract was shown to inhibit platelet aggregation and to inhibit eicosanoid synthesis, suggesting that it might have potent antiinflammatory properties. A 13% aqueous extract was tested orally in three dose levels (1, 5 and 10 ml/kg) on the carrageenan rat paw oedema model and on adjuvant-induced arthritis in rats. In both models, the extract showed potent dose-related antiinflammatory activity, which compared well with that of diclofenac (as a reference standard). The extract was then tested on an isolated sensitized guinea pig lung preparation to study its effect on the release of prostaglandins, leukotrienes and histamine. It is concluded that propolis extract has potent antiinflammatory properties in vivo. Its activity can be well correlated with its effects on the release of various mediators of inflammation.
Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Própole/farmacologia , Animais , Artrite Experimental/prevenção & controle , Carragenina , Diclofenaco/farmacologia , Dinoprostona/metabolismo , Relação Dose-Resposta a Droga , Edema/induzido quimicamente , Edema/prevenção & controle , Cobaias , Liberação de Histamina/efeitos dos fármacos , Técnicas In Vitro , Inflamação/induzido quimicamente , Inflamação/prevenção & controle , Leucotrieno D4/metabolismo , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Masculino , Prostaglandinas/metabolismo , RatosRESUMO
The protective effect of honeybee aqueous propolis extract (APE) against the hepatotoxicity of carbon tetrachloride was investigated using isolated liver-cell suspensions as the experimental model. Various concentrations of the extract were preincubated with the hepatocyte suspensions for 30 min before being subjected to the hepatotoxin for a further 30 min. The hepatocyte toxicity was assessed using three parameters, namely, the release of lactate dehydrogenase, the formation of lipid peroxides and the depletion of intracellular reduced glutathione. It was found that a dose-related protection against the induced cell injury was conferred by APE as evidenced by its inhibitory influence on the changes induced by CCl4 on the measured parameters. The hepatocyte protective effect of APE is probably a result of its antioxidant and free-radical-scavenging properties which in turn help to maintain the intracellular level of reduced glutathione.
Assuntos
Tetracloreto de Carbono/toxicidade , Fígado/efeitos dos fármacos , Própole/farmacologia , Animais , Tetracloreto de Carbono/antagonistas & inibidores , Células Cultivadas , Glutationa/metabolismo , L-Lactato Desidrogenase/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/metabolismo , Masculino , RatosRESUMO
Hypercholesterolemia is known to affect the responsiveness of various blood vessels to endogenous and to exogenous vasoactive agents. Of particular interest is the increased responsiveness to vasoconstrictors, e.g., 5-hydroxy tryptamine and noradrenaline, and the decreased reactivity towards vasodilators, e.g., acetylcholine. This, together with the development of arteriosclerosis, could play an important role in the progression of many vascular complications, such as hypertension and coronary heart disease. Magnesium pyridoxal 5-phosphate glutamate (MPPG) has been shown to effectively reduce serum lipids in animals and in man, and to retard the progression of atherosclerotic lesions in experimental animals. It was therefore considered of interest to investigate the reactivity of both the aorta and the renal artery to different vasoactive substances in hypercholesterolemic rabbits under the influence of MPPG as well as the effect of such substances on the blood pressure of the anesthetized animals. The rabbits were fed a high cholesterol diet for 2 months, followed by MPPG for 1 month, while keeping the rabbits on the same diet. One batch of animals was used for blood pressure recording and testing drug effects, and another was used for testing the responsiveness of their aortae and renal arteries to the different mediators. In hypercholesterolemic rabbits, treatment with MPPG tended to normalize the increased responsiveness of the blood pressure to the vasoconstrictors: noradrenaline and angiotensin and the diminished sensitivity to histamine and acetylcholine. For the isolated arteries, however, MPPG did not significantly affect the responses to noradrenaline nor potassium chloride, but tended to normalize responses to clonidine and acetylcholine. It could be concluded from the present findings that the high cholesterol diet induces changes in vascular reactivity which are possibly related to endothelial and/or receptor sensitivity changes. Treatment with MPPG helps to reverse these changes and to restore normal vascular reactivity, a fact that could have important clinical implications in the management of cardiovascular diseases.
Assuntos
Pressão Sanguínea/efeitos dos fármacos , Colesterol na Dieta/efeitos adversos , Glutamina/uso terapêutico , Hipercolesterolemia/tratamento farmacológico , Hipolipemiantes/uso terapêutico , Fosfato de Piridoxal/uso terapêutico , Sistema Vasomotor/efeitos dos fármacos , Acetilcolina/farmacologia , Angiotensina II/farmacologia , Animais , Clonidina/farmacologia , Avaliação Pré-Clínica de Medicamentos , Histamina/farmacologia , Hipercolesterolemia/etiologia , Técnicas In Vitro , Masculino , Norepinefrina/farmacologia , Coelhos , Vasoconstritores/farmacologiaRESUMO
The isolated perfused lung preparation from actively sensitized guinea-pigs was used; after it was challenged with antigen, mediators such as histamine, prostaglandins and leukotrienes were released into the lung effluent. It was found that treatment of the perfused lungs before and during challenge with mofebutazone (10 micrograms/ml) inhibited the immunological release of prostaglandins as well as leukotrienes. Phenylbutazone, on the other hand, at the same dose level inhibited the release of prostaglandins, whereas the release of leukotrienes was much less affected by the drug. Histamine release was not altered by either drug. When clinically mofebutazone tablets (300 mg) were given as an analgesic twice daily for 15 days to a number of asthmatic volunteers including 3 aspirin-sensitive individuals, there was no increase in the incidence or intensity of the asthmatic attacks, even in the aspirin-sensitive patients. Pulmonary ventilatory functions which showed a certain obstructive pattern were not worsened by the treatment and even tended to be somewhat improved.
Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Asma/tratamento farmacológico , Antagonistas de Leucotrienos , Pulmão/efeitos dos fármacos , Fenilbutazona/análogos & derivados , Adulto , Animais , Asma/fisiopatologia , Feminino , Cobaias , Humanos , Técnicas In Vitro , Pulmão/imunologia , Masculino , Pessoa de Meia-Idade , Fenilbutazona/farmacologia , Testes de Função RespiratóriaRESUMO
Twenty-seven human volunteer asthmatic patients were each given one tablet of mofebutazone (300 mg) twice daily for 15 days. Pulmonary ventilatory function test (forced expiratory volume test) as well as bronchoalveolar lavage (BAL) were performed one day before initiation of treatment and one day after completion of the course; in the BAL, prostaglandin E2 (PGE2), prostaglandin F2alpha (PGF2alpha) and leukotrienes (LTs) were also estimated. It was found that there was no increase in the incidence or severity of the asthmatic attacks during the course of mofebutazone treatment. The drug tended to improve the tested pulmonary ventilatory functions or at least to leave them unchanged. All the mofebutazone-treated individuals showed a dramatic reduction in the concentrations of PGE2, PGF2alpha and LTs in their BAL, but there was no consistent correlation between the extent of reduction and the degree of benefit or worsening sustained by any individual patient. It is evident from the present study that mofebutazone has shown good tolerability which was associated with an improvement in the pulmonary ventilatory functions, a fact that would seem to advocate the use of this non-steroidal antiinflammatory drug (NSAID) in asthmatic patients whenever a need for such therapy becomes necessary.
Assuntos
Anti-Inflamatórios não Esteroides/uso terapêutico , Asma/prevenção & controle , Fenilbutazona/análogos & derivados , Adulto , Anti-Inflamatórios não Esteroides/efeitos adversos , Anti-Inflamatórios não Esteroides/química , Feminino , Volume Expiratório Forçado/fisiologia , Humanos , Masculino , Fenilbutazona/efeitos adversos , Fenilbutazona/química , Fenilbutazona/uso terapêutico , Capacidade Vital/fisiologiaRESUMO
BACKGROUND: Hyperthermia produces marked effects on many biochemical parameters of tumor cells and has been reported to potentiate the effect of many drugs. We therefore evaluated the possible synergistic effect between hyperthermia and cisplatin against solid Ehrlich carcinoma. The study was based on the measurement of some biologic characteristics in tumor tissues, namely: DNA, RNA, and protein content and their rate of synthesis as parameters for nuclear damage; total lipids and cholesterol as parameters for membrane damage; acid-phosphatase and acid-ribonuclease as parameters for lysosomal damage; and tumor volume as a direct parameter for tumor growth. METHODS: Treatment of solid Ehrlich carcinoma by hyperthermia at 43 degrees C for 30 min for 3 successive days produced a 41.5% decrease in tumor volume, as well as a significant decrease in nucleic acids, protein contents and their rate of synthesis, in total lipids and cholesterol, and in acid-phosphatase and acid-ribonuclease. Chemotherapeutic management of the tumor by 5 mg/kg x 3 of cisplatin alone showed a continuous increase in tumor volume but at a lower rate than that of the untreated control. However, when cisplatin was given 1 h prior to hyperthermia, the tumor volume was significantly decreased by 82.6%. RESULTS: The effects observed on all the investigated parameter were intensified when cisplatin was combined with hyperthermia. The results obtained suggest that hyperthermia may enhance the penetration of cisplatin to its target site inside the tumor cells due to a membrane-damaging effect. The enhanced lethality of cisplatin on tumor cells may also be due to the inhibition of DNA repair processes by hyperthermia.